Amgen Requires Patients in Repatha Copay Program To Surrender Their Privacy

The tumult over the new cholesterol drugs just got a little more tumultuous. In addition to the existing controversies involving the high cost of the drugs and the fact that their clinical benefit has not yet been demonstrated, it now turns out that in order to afford one of these expensive new drugs some patients will...Click here to continue reading...
Source: CardioBrief - Category: Cardiology Authors: Tags: People, Places & Events Policy & Ethics Prevention, Epidemiology & Outcomes copay PCSK9 privacy Source Type: blogs